Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
159,2 INR | +2,02% | -4,04% | -1,15% |
Attività
Numero di dipendenti: 852
Vendite per attività
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 14 908 | 100,0 % | 18 521 | 100,0 % | +24,23% |
Vendite per regione
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States & North America
41,8
%
| 6 351 | 42,6 % | 7 746 | 41,8 % | +21,97% |
Europe and United Kingdom
41,4
%
| 6 091 | 40,9 % | 7 676 | 41,4 % | +26,02% |
Australia and New Zealand
11,3
%
| 1 798 | 12,1 % | 2 095 | 11,3 % | +16,51% |
Rest of World
5,2
%
| 669 | 4,5 % | 971 | 5,2 % | +45,10% |
India
0,2
%
| - | - | 34 | 0,2 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 52 | 16/04/92 | |
Director of Finance/CFO | 54 | 06/09/02 | |
Compliance Officer | - | - | |
Director/Board Member | 70 | 05/07/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Sunny Sharma
BRD | Director/Board Member | 49 | 11/08/21 |
Chief Executive Officer | 52 | 16/04/92 | |
Director/Board Member | 52 | 25/09/14 | |
Director/Board Member | 70 | 05/07/16 | |
Director/Board Member | 51 | 14/03/18 | |
Director/Board Member | 71 | 05/10/11 | |
Director/Board Member | 54 | 01/05/16 | |
Shailaja Vardhan
BRD | Director/Board Member | 58 | 31/05/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 453 163 746 | 253 747 549 ( 55,99 %) | 0 | 55,99 % |
Coordinate società
Marksans Pharma Ltd.
Oshiwara, Andheri West Grandeur, Veera Desai Extension Road
400053, Mumbai
+91 22 4001 2000
http://www.marksanspharma.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Time-Cap Laboratories, Inc.
Time-Cap Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Time-Cap Laboratories, Inc. offers pharmaceutical tablets and capsules. It offers diverse formulations including analgesics, laxatives, dietary supplements, cough & cold medications, prescription drugs, and several other products. The company was founded in 1979 and is headquartered in Farmingdale, NY. |
Pharmaceuticals: Major
|
Settore
Vendite per regione
Revisioni EPS
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-1,15% | 864 Mln | |
+30,38% | 684 Mrd | |
+26,51% | 568 Mrd | |
-4,36% | 361 Mrd | |
+19,30% | 329 Mrd | |
+3,73% | 284 Mrd | |
+16,70% | 240 Mrd | |
+8,78% | 208 Mrd | |
-7,93% | 200 Mrd | |
+7,68% | 166 Mrd |
- Borsa valori
- Azioni
- Azione MARKSANS
- Società Marksans Pharma Limited